Lupin on Thursday announced that it would be re-introducing its Methergine (methylergonovine maleate) tablets.
The researchers are currently conducting a National Health and Medical Research Council study using a combination of these nutraceuticals for depression.
The drug is a synthetic androgen available in 100-count bottles of 10-mg tablets.
The drug is indicated to treat attention deficit/hyperactivity disorder (ADHD) in children aged 6 years and older.
Dr. Reddy’s Laboratories subsidiary Promius Pharma announced Tuesday that its Zembrace SymTouch (sumatriptan injection) is now commercially available in the United Stated.
Biologic medications — nine of which were among the Food and Drug Administration’s approvals in 2015 — constitute a big portion of the specialty market.